States are not equipped to oversee hospital mergers under certificate of public advantage laws, a new paper from the Federal Trade Commission concluded, Modern Healthcare reports. Some states have allowed hospitals to merge via COPAs, shielding the merging parties from federal antitrust scrutiny in exchange for prolonged state oversight. While hospital executives and state officials claim that mergers under COPAs will lead to lower costs and better outcomes, some transactions have produced the opposite results, the FTC said Monday in an analysis of hospital deals. Read more.
Related Posts
What’s in it for Evernorth? Cigna’s Health Services Arm Invests $2.5B in VillageMD-Summit
The deal could have major ramifications on Evernorth’s push to value-based care, according to Cigna executives and analysts.
November 11, 2022
Briefs Sealed in UnitedHealth and Change Antitrust Trial
The DOJ has said the merger would likely substantially lessen competition in the market.
September 1, 2022
Health Systems Look to Emulate a ‘Retail Health’ Environment
Retail disruptors often excel in delivering customer-centric experiences.
November 13, 2023
CMS to Get ‘Tougher’ on Medicare Advantage, Official Promises
MA plans — which now cover more than half of Medicare beneficiaries — have faced rising criticism over care denials and access, along with improper coding practices that inflate the program’s cost.
September 25, 2023